Skip to main content

Peer Review reports

From: Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats

Original Submission
1 Jun 2018 Submitted Original manuscript
5 Jul 2018 Author responded Author comments - Changhe Liu
Resubmission - Version 2
5 Jul 2018 Submitted Manuscript version 2
12 Aug 2018 Reviewed Reviewer Report - Dawood Darbar
14 Aug 2018 Reviewed Reviewer Report - B. Maura Greiser
27 Aug 2018 Author responded Author comments - Changhe Liu
Resubmission - Version 3
27 Aug 2018 Submitted Manuscript version 3
17 Sep 2018 Reviewed Reviewer Report - B. Maura Greiser
23 Sep 2018 Author responded Author comments - Changhe Liu
Resubmission - Version 4
23 Sep 2018 Submitted Manuscript version 4
31 Oct 2018 Author responded Author comments - Changhe Liu
Resubmission - Version 5
31 Oct 2018 Submitted Manuscript version 5
3 Nov 2018 Author responded Author comments - Changhe Liu
Resubmission - Version 6
3 Nov 2018 Submitted Manuscript version 6
Publishing
9 Nov 2018 Editorially accepted
13 Dec 2018 Article published 10.1186/s12872-018-0950-x

You can find further information about peer review here.

Back to article page